Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin bolus plus infusion versus bolus alone for postpartum haemorrhage prevention after elective caesarean section
ACTRN12607000631404Phase 4Terminated
- Sponsor
- Monash University
- Start
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxytocin in postpartum hemorrhage (PPH) and uterine atony (2 arms), sponsored by Monash University. Primary endpoint: Requirement for additional uterotonic measures. Started Mar 2008; status: terminated.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)uterine atony
Beyond the preview
Go deeper on ACTRN12607000631404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000631404.